Table of Contents
1 Market Overview
1.1 Glycosylated Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glycosylated Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 mAb
1.2.3 EPO
1.3 Market Analysis by Application
1.3.1 Overview: Global Glycosylated Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Overview of Global Glycosylated Biosimilars Market
1.4.1 Global Glycosylated Biosimilars Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sandoz
2.1.1 Sandoz Details
2.1.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sandoz SWOT Analysis
2.1.4 Sandoz Product and Services
2.1.5 Sandoz Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celltrion
2.3.1 Celltrion Details
2.3.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celltrion SWOT Analysis
2.3.4 Celltrion Product and Services
2.3.5 Celltrion Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Samsung Biologics
2.5.1 Samsung Biologics Details
2.5.2 Samsung Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Samsung Biologics SWOT Analysis
2.5.4 Samsung Biologics Product and Services
2.5.5 Samsung Biologics Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pahrmaceutical
2.6.1 Teva Pahrmaceutical Details
2.6.2 Teva Pahrmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pahrmaceutical SWOT Analysis
2.6.4 Teva Pahrmaceutical Product and Services
2.6.5 Teva Pahrmaceutical Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Stada Arzneimittel AG
2.7.1 Stada Arzneimittel AG Details
2.7.2 Stada Arzneimittel AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Stada Arzneimittel AG SWOT Analysis
2.7.4 Stada Arzneimittel AG Product and Services
2.7.5 Stada Arzneimittel AG Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biocon
2.9.1 Biocon Details
2.9.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biocon SWOT Analysis
2.9.4 Biocon Product and Services
2.9.5 Biocon Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dr. Reddy’s Laboratories
2.10.1 Dr. Reddy’s Laboratories Details
2.10.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dr. Reddy’s Laboratories SWOT Analysis
2.10.4 Dr. Reddy’s Laboratories Product and Services
2.10.5 Dr. Reddy’s Laboratories Glycosylated Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glycosylated Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glycosylated Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glycosylated Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Glycosylated Biosimilars Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glycosylated Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Glycosylated Biosimilars Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glycosylated Biosimilars Revenue and Market Share by Regions (2015-2020)
4.2 North America Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.3 Europe Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.5 South America Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glycosylated Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 United States Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
5.3 Canada Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
5.4 Mexico Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glycosylated Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
6.2 Germany Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.3 UK Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.4 France Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.5 Russia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
6.6 Italy Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glycosylated Biosimilars Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glycosylated Biosimilars Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glycosylated Biosimilars Revenue and Market Share by Regions (2015-2020)
7.2 China Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.3 Japan Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.4 Korea Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.5 India Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
7.7 Australia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glycosylated Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
8.1.2 South America Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
8.3 Argentina Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glycosylated Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glycosylated Biosimilars Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glycosylated Biosimilars Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9.3 Turkey Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9.4 Egypt Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Africa Glycosylated Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glycosylated Biosimilars Sales and Market Share by Type (2015-2020)
10.2 Global Glycosylated Biosimilars Revenue and Market Share by Type (2015-2020)
10.3 Global Glycosylated Biosimilars Price by Type (2015-2020)
11 Global Glycosylated Biosimilars Market Segment by Application
11.1 Global Glycosylated Biosimilars Sales Market Share by Application (2015-2020)
11.2 Global Glycosylated Biosimilars Revenue Market Share by Application (2015-2020)
11.3 Global Glycosylated Biosimilars Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glycosylated Biosimilars Sales, Revenue and Growth Rate (2021-2025)
12.2 Glycosylated Biosimilars Market Forecast by Regions (2021-2025)
12.2.1 North America Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.2 Europe Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.4 South America Glycosylated Biosimilars Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glycosylated Biosimilars Market Forecast (2021-2025)
12.3 Glycosylated Biosimilars Market Forecast by Type (2021-2025)
12.3.1 Global Glycosylated Biosimilars Sales Forecast by Type (2021-2025)
12.3.2 Global Glycosylated Biosimilars Market Share Forecast by Type (2021-2025)
12.4 Glycosylated Biosimilars Market Forecast by Application (2021-2025)
12.4.1 Global Glycosylated Biosimilars Sales Forecast by Application (2021-2025)
12.4.2 Global Glycosylated Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
Sandoz、Mylan、Celltrion、Pfizer、Samsung Biologics、Teva Pahrmaceutical、Stada Arzneimittel AG、Amgen、Biocon、Dr. Reddy's Laboratories、
【免責事項】
https://www.globalresearch.jp/disclaimer